Biologic therapies in type 2 asthma: mechanisms, clinical evidence, and impact in high-altitude populations
Abstract Asthma is a common chronic airway disease, and type 2 asthma is typically characterised by eosinophilic airway inflammation and a suboptimal response to conventional therapies. The advent of biologic agents has driven a paradigm shift towards precision medicine in asthma management. However...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SpringerOpen
2026-03-01
|
| Edice: | The Egyptian Journal of Bronchology |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s43168-026-00546-y |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|